Form 8-K - Current report:
SEC Accession No. 0001731122-24-001750
Filing Date
2024-11-08
Accepted
2024-11-08 16:32:57
Documents
14
Period of Report
2024-11-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e6107_8k.htm   iXBRL 8-K 30077
2 EXHIBIT 10.1 e6107_ex10-1.htm EX-10.1 36388
  Complete submission text file 0001731122-24-001750.txt   250968

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE renb-20241104.xsd EX-101.SCH 3030
4 XBRL LABEL FILE renb-20241104_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE renb-20241104_pre.xml EX-101.PRE 24175
16 EXTRACTED XBRL INSTANCE DOCUMENT e6107_8k_htm.xml XML 3683
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 241441191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)